GDBspace, a Space Pharmaceuticals company, announces a pilot project with a world leading cosmetic company to apply GDBspace’s technologies
GDBspace AG, a company specializing in computational methods for molecule discovery, today announces a pilot project with a leading cosmetics company.
GDBspace, a Space Pharmaceuticals company, enters into a licensing agreement with Humanwell Healthcare, for the discovery of Covid-19 inhibitors using GDBspace’s chemical space drug discovery engine
GDBspace AG, a company specialized in computational methods for drug discovery, today announced that it entered into a sponsored research agreement with Ruibeixiyu Biotech, for the design of Covid-19 inhibitors for treatment of coronavirus infections.
GDBspace, a Space Pharmaceuticals company, announces today a collaboration with a world leading pharmaceutical company to leverage GDBspace’s technology platform
GDBspace AG, a company specializing in computational methods for drug discovery, today announces a proof-of-concept collaboration with a leading pharmaceutical company to support them explore large databases and select compounds of interests.
GDBspace, a Space Pharmaceuticals company, announces the beginning of a strategic collaboration with the University of Bern, Switzerland
GDBspace, a Space Pharmaceuticals company, is pleased to establish an annual collaboration with the University of Bern, Switzerland, embedded within the Department of Chemistry, Biochemistry & Pharmaceutical Sciences. The collaboration will capitalize on the world-class research environment in Bern, leveraging expertise and resources from both Space Pharmaceuticals and the University to drive innovation within computational-based drug discovery. By using GDBspace’s unique […]
GDBspace, a Space Pharmaceuticals company, is supported by Innosuisse
GDBspace, a Space Pharmaceuticals company, is supported by Innosuisse, the Swiss Federal Innovation Agency.